To further strengthen academic research, exchanges and cooperation in stroke prevention and treatment at home and abroad, promote the formulation of standardized clinical practice guidelines for stroke prevention and treatment in China, elevate the clinical research capacity in stroke care, standardize clinical diagnosis and treatment among healthcare professionals, boost China’s global influence in stroke research and clinical practice, reduce the incidence, recurrence, disability and mortality rates of stroke, and improve public health, the Chinese Stroke Association was established upon approval by the China Association for Science and Technology and the Ministry of Civil Affairs. Its First National Congress of Members was convened in Beijing on January 18, 2015.

This marked the official founding of China’s first national-level academic organization dedicated to cerebrovascular diseases.

 

Jiangsu Province is among China’s economically developed regions with generally high living standards. However, this has been accompanied by high prevalence rates of overweight, hypertension, diabetes and dyslipidemia. These risk factors contribute to a steady rise in stroke incidence and increase the likelihood of adverse outcomes following a stroke. Therefore, it is imperative to enhance clinical research in stroke prevention and treatment, standardize clinical practice for healthcare workers in the province, cut stroke incidence, recurrence, disability and mortality, and improve the health of local residents.

 

The establishment of the Jiangsu Stroke Association will enable integration and coordination of multidisciplinary resources covering neurology, neurosurgery, cardiology, endocrinology, emergency medicine, clinical laboratory sciences, neuroimaging, rehabilitation medicine and epidemiology. By pooling strengths across disciplines and uniting separate efforts into joint forces, a multidisciplinary collaborative prevention and treatment model can be developed. This will effectively lower stroke incidence among healthy populations and reduce risks of poor prognosis in stroke patients, contributing to elevating Jiangsu’s influence in domestic and international stroke research and clinical care.

 

Website: https://www.jssczxh.com/